AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Auraglik-M60 XR Tablet SR

Prescription Icon
Prescription Required

Marketer

Aura Lifecare Private Limited

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Auraglik-M60 XR Tablet SR

Diabexe-Duo 60mg XR tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. This medication helps regulate blood glucose. Always take Diabexe-Duo 60mg XR with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, potentially causing kidney problems, vision loss, neuropathy, and limb complications. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary foods or juice) to manage hypoglycemia. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your physician of any prior heart conditions before commencing treatment; pregnancy or breastfeeding necessitates medical consultation. Regular blood glucose monitoring and potential blood tests (blood cell counts and liver function) will be advised by your doctor.

Uses of Auraglik-M60 XR Tablet SR

Adult-onset diabetes

Major Benefits of Auraglik-M60 XR Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Auraglik-M60 XR Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Auraglik-M60 XR Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Auraglik-M60 XR Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Auraglik-M60 XR Tablet SR with a meal.

How Auraglik-M60 XR Tablet SR works:

Extended-release Auraglik-M60 tablets contain a dual-action formulation of gliclazide and metformin, both used in the management of diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Auraglik-M60 XR Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Auraglik-M60 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Auraglik-M60 tablets are likely unsafe for breastfeeding mothers. Preliminary human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Auraglik-M60 XR Tablet SR, potentially requiring a modified dosage. Physician consultation is necessary. Auraglik-M60 XR Tablet SR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Auraglik-M60 XR Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Auraglik-M60 XR Tablet SR :

Should you forget a dose of Auraglik-M60 XR Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Auraglik-M60 XR Tablet SR

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Auraglik-M60 XR Tablet SR

Auraglik-M60 XR Tablet SR combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a healthy diet and exercise regimen. Gliclazide stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes.
Aruglik-M60 XR Tablet SR may cause frequent adverse reactions such as low blood glucose, taste disturbances, queasiness, abdominal discomfort, loose stools, cephalalgia, and upper respiratory illnesses. Rare but potentially severe complications, including lactic acidosis, are also possible. Prolonged therapy may result in vitamin B12 insufficiency.
Aintraglik-M60 XR extended-release tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremors. These are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are concurrently used. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Aruglik-M60 XR Tablet SR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon complication of metformin treatment. It's crucial to avoid its use in individuals with pre-existing kidney problems, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Aruglik-M60 XR Tablet SR and seek immediate medical attention.
Prolonged Auraglik-M60 XR Tablet SR administration can indeed lead to vitamin B12 deficiency. This deficiency arises from the medication's interference with gastric vitamin B12 absorption. Left unaddressed, this can result in anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of annually, is recommended by some studies.
Auraglik-M60 XR Tablet SR is contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. Its use is also prohibited in patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Auraglik-M60 XR Tablet SR is unsafe. This combination risks reduced blood glucose (hypoglycemia) and heightened lactic acidosis probability.
Auralik-M60 XR extended-release tablets contain gliclazide and metformin, employed in managing type 2 diabetes. This dual-drug therapy enhances glycemic control in adults when coupled with dietary modification and physical activity. Gliclazide stimulates pancreatic insulin secretion, reducing blood glucose, while metformin decreases hepatic glucose output and augments insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Auraglik-M60 XR Tablet SR may cause common adverse reactions such as low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Less frequent, but serious, side effects include lactic acidosis. Prolonged therapy might also result in vitamin B12 deficiency.
Indeed, Auraglik-M60 XR Tablet SR may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Aruglik-M60 XR Tablet SR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this is an uncommon adverse reaction to metformin. Risk is heightened in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Aruglik-M60 XR Tablet SR and seek immediate medical attention.
Prolonged Auraglik-M60 XR Tablet SR use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency may manifest as anemia, neurological complications including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Aruglik-M60 XR Tablet SR is contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. Its use is also prohibited in patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Auraglik-M60 XR Tablet SR is unsafe. This combination may lead to dangerously low blood sugar and heighten the risk of lactic acidosis.
Auraglik-M60 XR Tablet SR
158
MRP 192
17% off